Vivanza Biosciences share news, announcements and annual reports
BSE: 530057Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 2 Nov 2026. Previous close ₹1.54.
2 Nov: open ₹1.49, high ₹1.49, low ₹1.46
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5.84 Cr4,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 12.86
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.34
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 56,005
Vivanza Biosciences share news and announcements
594 announcements, routine notices left out, newest first. Page 10 of 12.
Jun 2017
May 2017
Apr 2017
26 Apr · Compliance Certificate For The Period Ended 31 March, 2017.
24 Apr · Certificate Under Regulation 40(9)For The Half Year Ended On 31/03/2017.
17 Apr · Statement Of Investor Complaint For The Quarter Ended March 31,2017.
13 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....10 Apr · Shareholding for the Period Ended April 10, 2017
Shareholding Pattern for the Period Ended April 10, 2017. For more details, kindly Click ....
Mar 2017
31 Mar · Conversion Of 14,50,000 Warrants Into Equivalent Number Of Equity Shares.
31 Mar · Board meeting
30 Mar · Board Meeting On March 31,2017.
16 Mar · Intimation For Independent Directors Meeting On March 24,2017.
Feb 2017
Jan 2017
21 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....18 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Nov 2016
Oct 2016
21 Oct · Shareholding for the Period Ended September 30, 2016
Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....16 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Sep 2016
29 Sep · Chairman's speech
6 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 26, 2016 to September 29, 2016 (both days inclusive) ....
Aug 2016
8 Aug · Board Meeting on August 11, 2016
4 Aug · Board Meeting on August 13, 2016
Jul 2016
22 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
21 Jul · Shareholding for the Period Ended June 30, 2016
Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....
Jun 2016
14 Jun · Board Meeting on June 17, 2016
Meeting of the Board of Directors of the Company will be held on June 17, 2016, inter alia: 1. To make allotment of 23,62,000 Equity ....13 Jun · Post Open Offer Status
May 2016
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has: - Considered and approved changing the Registrar ....23 May · Updates on Open Offer
17 May · Updates on Open Offer
Apr 2016
21 Apr · Shareholding for the Period Ended March 31, 2016
Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....20 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Mar 2016
30 Mar · Outcome of lndependent Directors Meeting